Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5 vs 10 days phenoxymethylpenicillin for streptococcal pharyngotonsillitis
2015-001752-30Phase 4Completed
- Sponsor
- Folkhälsomyndigheten
- Start
- May 2015
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of phenoxymethylpenicillin in streptococcal pharyngitis (2 arms), sponsored by Folkhälsomyndigheten. Primary endpoint: Clinical cure. Started May 2015; status: completed.
02
Drugs
phenoxymethylpenicillin
03
Conditions
streptococcal pharyngitis
Beyond the preview
Go deeper on 2015-001752-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001752-30.